Hidradenitis Suppurativa

• CLINICAL_TRIALS trial_result · 2017-11-24
  Clinical Trial Update: Treatment of Hidradenitis Suppurativa Using Etanercept

  A completed clinical trial evaluated the use of etanercept to treat hidradenitis suppurativa.

• CLINICAL_TRIALS trial_result · 2017-10-12
  Clinical Trial Update: Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa

  A completed clinical trial assessing quality of life after wide surgical excision in patients with hidradenitis suppurativa.

• CLINICAL_TRIALS trial_result · 2017-09-19
  Clinical Trial Update: Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

  Phase 2 trial investigating complement inhibition for moderate to severe hidradenitis suppurativa has completed.

• CLINICAL_TRIALS trial_result · 2017-09-05
  Clinical Trial Update: Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa [Phase 3]

  Open-label Phase 3 trial evaluating safety and efficacy of adalimumab in hidradenitis suppurativa has completed with results posted in 2017.

• CLINICAL_TRIALS research · 2017-06-29
  Clinical Trial Update: Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa [NA]

  A clinical trial update on using Intense Pulsed Light Therapy to treat hidradenitis suppurativa (acne inversa), sponsored by Zealand Univers…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-03-01
  Clinical Trial Update: MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB [Phase 2]

  Phase 2 trial evaluating MABp1 for hidradenitis suppurativa in patients refractory to adalimumab has completed.

• CLINICAL_TRIALS research · 2016-12-22
  Clinical Trial Update: Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact

  A clinical trial update comparing psychological impact in patients with hidradenitis suppurativa versus psoriasis.

• CLINICAL_TRIALS research · 2016-09-22
  Clinical Trial Update: Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life [NA]

  This entry summarizes a trial evaluating group psychotherapy for hidradenitis suppurativa and its effects on quality of life.

• CLINICAL_TRIALS trial_result · 2016-09-01
  Clinical Trial Update: Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

  Phase 2 study of MEDI8968 for moderate-to-severe hidradenitis suppurativa was terminated, with results posted in 2016.

• FDA approval · 2016-06-30
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved a supplemental application for Humira (adalimumab) to Cordavis Limited, authorizing the continued manufacturing/supply of the p…

• FDA approval · 2015-11-23
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…

• CLINICAL_TRIALS trial_result · 2015-10-28
  Clinical Trial Update: Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa [Phase 3]

  Phase 3 trial of adalimumab for hidradenitis suppurativa completed with posted results.

• CLINICAL_TRIALS trial_result · 2015-10-28
  Clinical Trial Update: Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa [Phase 3]

  Phase 3 trial update for adalimumab in hidradenitis suppurativa completed with posted results in 2015.

• EMA approval · 2015-06-26
  First medicine recommended for approval for hidradenitis suppurativa

  The EMA recommends the first medicine for approval to treat hidradenitis suppurativa, marking a landmark for this condition in Europe.

• CLINICAL_TRIALS trial_result · 2015-05-27
  Clinical Trial Update: Anakinra in Hidradenitis Suppurativa [Phase 2]

  Phase 2 trial of Anakinra for hidradenitis suppurativa has completed.

• CLINICAL_TRIALS trial_result · 2015-04-07
  Clinical Trial Update: To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa [Phase 3]

  Phase 3 trial evaluating a laser therapy device for hidradenitis suppurativa. The study was terminated.

• FDA approval · 2014-09-30
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved Humira's supplemental application submitted by Cordavis Limited. The approval acts as a supplemental approval to the existing H…

• CLINICAL_TRIALS trial_result · 2014-08-06
  Clinical Trial Update: Anakinra as a Treatment for Hydradenitis Suppurativa [Phase 2]

  Phase 2 clinical trial evaluating anakinra for hidradenitis suppurativa has completed with results posted in 2014.

• FDA approval · 2014-05-30
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited under BLA125057.

• CLINICAL_TRIALS trial_result · 2014-01-16
  Clinical Trial Update: A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS [Phase 2]

  Phase 2 trial evaluating the safety and efficacy of YAZ (drospirenone/ethinyl estradiol) versus placebo for hidradenitis suppurativa was ter…

• FDA approval · 2013-04-24
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.

• FDA approval · 2012-09-28
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  The FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.

• FDA approval · 2012-05-24
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.

• FDA approval · 2011-12-26
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  The FDA has approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.

• FDA approval · 2011-12-13
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.